Medtronic personnel shuffle
This article was originally published in The Gray Sheet
Executive Summary
Charles Swanson is heading up Medtronic's corporate regulatory affairs office following the Aug. 31 retirement of Peter Chevalier, former VP and chief quality and regulatory officer at the company. Swanson, who assumes the title VP-corporate regulatory affairs effective Sept. 1, had led the regulatory affairs department at Medtronic's pacing division. Senior Legal Counsel Robert Klepinski also joins the corporate regulatory affairs office, as does Kenneth Kopesky, director, pacing regulatory compliance. Former VP Corporate Regulatory Affairs Fred Halverson is named VP-international regulatory strategy and reimbursement policy